NASDAQ: DRIODariohealth Corp Stock Ownership - Who owns Dariohealth?
Insider buying vs selling
Have Dariohealth Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven Charles Nelson | Chief Commercial Officer | 2024-11-12 | 5,000 | $0.91 | $4.55kBuy |
| Steven Charles Nelson | Chief Commercial Officer | 2024-09-11 | 5,000 | $0.80 | $4.02kBuy |
| Steven Charles Nelson | Chief Commercial Officer | 2024-09-10 | 5,000 | $0.84 | $4.22kBuy |
| Steven Charles Nelson | Chief Commercial Officer | 2024-09-09 | 5,000 | $0.80 | $4.00kBuy |
| Steven Charles Nelson | Chief Commercial Officer | 2024-09-06 | 5,000 | $0.84 | $4.20kBuy |
| Steven Charles Nelson | Chief Commercial Officer | 2024-09-05 | 5,000 | $0.82 | $4.09kBuy |
DRIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DRIO insiders and whales buy or sell their stock.
DRIO Shareholders
What type of owners hold Dariohealth Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| David Weintraub | 5.93% | 2,700,000 | $1.49M | Insider |
| Yossi Bahagon | 5.05% | 2,295,704 | $1.26M | Insider |
| Erez Raphael | 4.34% | 1,974,935 | $1.09M | Insider |
| Oren Fuerst | 3.79% | 1,725,000 | $948.75k | Insider |
| Nantahala Capital Management LLC | 3.72% | 1,692,303 | $930.77k | Institution |
| Shehnee Farhi | 2.86% | 1,301,000 | $715.55k | Insider |
| Appian Way Asset Management LP | 2.82% | 1,280,880 | $704.48k | Institution |
| Phoenix Financial Ltd | 2.48% | 1,126,736 | $619.70k | Institution |
| Allen Kamer | 2.18% | 990,067 | $544.54k | Insider |
| Ourcrowd Digital Health LP | 1.96% | 892,858 | $491.07k | Insider |
DRIO vs Diagnostic & Research Stocks
Dariohealth Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.